ストックスクリーナーアプリを入手
16.01
0.93%
-0.15
Indivior Plc (INDV) 最新ニュース
What analysts say about Indivior PLC stockBreakthrough capital growth - Autocar Professional
What drives Indivior PLC stock priceExplosive capital gains - Autocar Professional
Is Indivior PLC a good long term investmentPhenomenal capital appreciation - Jammu Links News
Indivior to Report Second Quarter 2025 Financial Results and Host Webcast on July 31st - Eastern Progress
Indivior PLC Stock Analysis and ForecastFree Real-Time Stock Data - Jammu Links News
Indivior PLC Executes Share Buyback Plan - TipRanks
Barclays Acquires Significant Stake in Indivior PLC - TipRanks
Indivior to Announce Q2 2025 Financial Results - TipRanks
Indivior to report Q2 2025 results on July 31 - Investing.com
Indivior to report Q2 2025 results on July 31 By Investing.com - Investing.com Nigeria
Indivior Sets Q2 2025 Earnings Release and Live Webcast: Key Details for Investors - Stock Titan
How To Trade (INDV) - news.stocktradersdaily.com
Indivior stock hits 52-week high at 15.9 USD By Investing.com - Investing.com Nigeria
Indivior stock hits 52-week high at 15.9 USD - Investing.com Australia
Levi & Korsinsky Notifies Indivior PLC Investors of a Class Action Lawsuit and Upcoming DeadlineINDV - ACCESS Newswire
Hawaii to receive up to $2.4M in latest opioid settlement - Spectrum News
Indivior Appoints Vanessa Procter as Executive Vice President of Corporate Affairs - PR Newswire
Indivior Strengthens Leadership: Former Sage Therapeutics SVP Joins to Advance Opioid Crisis Solutions - Stock Titan
Shareholders that Lost Money on Indivior PLC (INDV) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
Indivior (INDV) Moves 5.7% Higher: Will This Strength Last? - MSN
Indivior stock hits 52-week high at $15.52 - Investing.com Australia
Indivior stock hits 52-week high at $15.52 By Investing.com - Investing.com Canada
Indivior PLC (INDV) Stock Price Up 4.02% on Jul 2 - GuruFocus
Indivior PLC Announces Change in Major Holdings by Barclays - The Globe and Mail
Indivior to join Russell 2000 Index - MSN
Indivior PLC Announces Changes in Major Shareholder Voting Rights - TipRanks
BlackRock Increases Stake in Indivior PLC - TipRanks
Indivior PLC Updates Share Capital and Voting Rights - TipRanks
Indivior price target raised to $22 from $16 at Northland - TipRanks
Indivior Announces Inclusion in the U.S. Russell 2000® and 3000® Indexes - GuruFocus
Indivior Joins U.S. Russell Indexes, Boosting Market Presence - TipRanks
Indivior appoints Tony Kingsley to board of directors - Investing.com
Two Seas Capital LP Increases Stake in Indivior PLC - GuruFocus
Indivior Appoints Tony Kingsley to the Board of Directors – Company Announcement - Financial Times
Indivior adds biopharmaceutical executive Kingsley to board By Investing.com - Investing.com UK
Indivior Presents New Data at CPDD Demonstrating that High Buprenorphine Exposure May Improve Treatment Outcomes in High Fentanyl Users - Longview News-Journal
Indivior PLC Announces Changes in Major Holdings - TipRanks
Wirral Council v Indivior/Reckitt: Supreme Court refuses permission to appeal representative action strike out - stewartslaw.com
Indivior PLC Corrects Director Shareholding Disclosure - TipRanks
REGIndivior PLCDirector/PDMR ShareholdingCorrection - TradingView
Naloxone Market to Reflect Significant Incremental - openPR.com
Indivior Directors Increase Stake in Company Shares - TipRanks
Suboxone Market Set to Witness Growth as Opioid Dependency - openPR.com
Substance Abuse Treatment Market Size, Trends & Growth - openPR.com
Indivior PLC Announces Changes in Major Shareholdings - MSN
Indivior-Funded Study Suggests Opvee Outperforms Narcan. But at What? - Filter
4.65%
大文字化:
|
ボリューム (24 時間):